Inventor

MADISON EDWIN L

US40 patents

⚠️ This page may combine multiple inventors who share the name “MADISON EDWIN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MADISON EDWIN L

MADISON EDWIN L

Protease screening methods and proteases identified thereby

Protease screening methods and proteases identified thereby

Factor VII polypeptides that are modified and uses thereof

Protease screening methods and proteases identified thereby

Modified factor IX polypeptides and uses thereof

Modified MT-SP1 proteases that inhibit complement activation

Modified factor IX polypeptides and uses thereof

Modified factor X polypeptides and uses thereof

CATALYST BIOSCIENCES INC

Factor VII polypeptides that are modified and uses thereof

Factor VII polypeptides that are modified and uses thereof

Factor VII polypeptides that are modified and uses thereof

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

Modified factor IX polypeptides and uses thereof

Modified factor X polypeptides and uses thereof

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

DENDREON CORP

Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon

Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon

Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon

Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon

Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon

Nucleic acids encoding endotheliases, endotheliases and uses thereof

Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon

UNIV TEXAS

Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors

Genes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors

Pai-1 mutants

U-PA mutants resistant to inhibition by their cognate inhibitors

Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same

VERTEX PHARMA

Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use

Modified urokinase-type plasminogen activator polypeptides and methods of use

Modified urokinase-type plasminogen activator polypeptides and methods of use

CORVAS INT INC

Plasminogen activator inhibitor antagonists

Non-covalent inhibitors of urokinase and blood vessel formation

Title inhibitors of urokinase

SCRIPPS RESEARCH INST

Tissue type plasminogen activator (t-PA) variants: compositions and methods of use

Tissue type plasminogen activator (t-PA) variants: compositions and methods of use

CORVAS INTERNAT INC

Plasminogen activator inhibitor antagonists

DYAX CORP

Endotheliase-2 ligands

DENDREON SAN DIEGO LLC

Inhibitors of serine protease activity of matriptase or MTSP1